Target intelligence / Profile preview

Apoptosis-inducing factor 1, mitochondrial and Endonuclease G (AIF and EndoG)

Target
AIF and EndoG
Molecular classification
Oxidoreductase, Nuclease, Mitochondrial protein
01

Overview

Apoptosis-inducing factor (AIF, specifically AIFM1) and Endonuclease G (EndoG) are mitochondrial proteins that serve as key mediators of caspase-independent cell death. Under normal physiological conditions, AIF functions as a flavin adenine dinucleotide (FAD)-dependent NADH oxidoreductase essential for mitochondrial respiratory chain assembly, while EndoG is involved in mitochondrial DNA maintenance and repair. Following cellular injury or pro-apoptotic signaling, these proteins are released from the mitochondrial intermembrane space and translocate to the nucleus. Once in the nucleus, AIF promotes chromatin condensation and recruits nucleases, while EndoG directly catalyzes DNA fragmentation, leading to a form of programmed cell death known as parthanatos or caspase-independent apoptosis. This pathway is critically involved in the pathogenesis of neurodegenerative diseases, stroke, and myocardial infarction, where excessive cell death occurs. Consequently, inhibitors of AIF translocation or PARP-1 (which triggers AIF release) are being investigated for neuroprotection, while the induction of this pathway is a potential strategy for treating apoptosis-resistant cancers.

Other names
AIFM1PDCD8ENDOGApoptosis-inducing factorEndoGMitochondrial nuclease
02

Mechanism of action

Inhibition of mitochondrial release, nuclear translocation, or DNA binding of AIF and EndoG; or indirect modulation of the pathway via PARP-1 inhibition to prevent PAR-mediated AIF release.

03

Biological functions

ApoptosisCell deathDNA fragmentationMitochondrial functionRedox metabolism
04

Disease associations

Neurodegenerative diseaseCancerStrokeCardiovascular diseaseIschemia-reperfusion injury
05

Safety considerations

Essential mitochondrial function of AIF in oxidative phosphorylation (OXPHOS)Potential for systemic toxicity due to inhibition of normal cell death processesRisk of mitochondrial dysfunction in healthy tissues
06

Interacting drugs

Olaparib

4 more in the full profile.

07

Biomarkers

Nuclear translocation of AIFNuclear translocation of EndoGDNA fragmentation (TUNEL)Poly(ADP-ribose) (PAR) accumulation

Beyond the preview

Go deeper on Apoptosis-inducing factor 1, mitochondrial and Endonuclease G (AIF and EndoG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis-inducing factor 1, mitochondrial and Endonuclease G (AIF and EndoG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call